Dexcom Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Dexcom Inc 公司

DexCom, Inc. 是一家醫療設備公司。該公司主要專注於設計、開發和商業化連續血糖監測 (CGM)，該系統用於患者、護理人員和臨牀醫生管理糖尿病和代謝健康。其產品包括 Dexcom G6、Dexcom G7、Stelo、Dexcom Share 和 Dexcom ONE。該公司通過創新的生物傳感技術讓人們掌控健康。Dexcom G6 是其集成的連續血糖監測系統 (iCGM)。Stelo 是專爲不使用胰島素的 II 型糖尿病患者設計的，是美國第一款非處方葡萄糖生物傳感器。Dexcom Share 遠程監控系統可與任何 Dexcom 系統一起使用，使用患者兼容移動設備上的應用程序。其 Dexcom G7 適用於患有 I 型或 II 型糖尿病的成人和兒童（2 歲以上），他們正在使用任何胰島素或藥物，有低血糖風險，以及患有妊娠糖尿病。

Dexcom Inc簡介



公司代碼DXCM

公司名稱Dexcom Inc

上市日期Apr 14, 2005

CEOMr. Jacob Steven (Jake) Leach

員工數量10300

證券類型Ordinary Share

年結日Apr 14

公司地址6340 Sequence Dr

城市SAN DIEGO

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編92121

電話18582000200

網址https://www.dexcom.com/

公司代碼DXCM

上市日期Apr 14, 2005

CEOMr. Jacob Steven (Jake) Leach

Dexcom Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Jacob Steven (Jake) Leach

President, Interim Principal Executive Officer, Chief Operating Officer, Director

276.26K

+6.52%

Mr. Mark G. Foletta

Interim Independent Chairman of the Board

62.13K

+4.65%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+4.13%

Mr. Richard Alexander Collins

Independent Director

44.38K

+5.82%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+6.12%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

35.33K

-12.01%

Ms. Bridgette P. Heller

Independent Director

28.04K

+21.94%

Mr. Kyle Malady

Independent Director

22.67K

-2.86%

Ms. Rimma Driscoll

Independent Director

9.04K

+127.87%

Ms. Renee D. Gala

Independent Director

6.88K

+20.30%

名稱

名稱/職務

職務

持股

持股變動

Mr. Jacob Steven (Jake) Leach

President, Interim Principal Executive Officer, Chief Operating Officer, Director

276.26K

+6.52%

Mr. Mark G. Foletta

Interim Independent Chairman of the Board

62.13K

+4.65%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+4.13%

Mr. Richard Alexander Collins

Independent Director

44.38K

+5.82%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+6.12%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

35.33K

-12.01%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Distributor

977.80M

84.50%

Direct

179.30M

15.50%

地區USD

名稱

營收

佔比

United States

841.00M

72.68%

Outside of United states

316.10M

27.32%

業務

地區

業務USD

名稱

營收

佔比

Distributor

977.80M

84.50%

Direct

179.30M

15.50%

股東統計

更新時間: 8月19日週二

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

12.28%

BlackRock Institutional Trust Company, N.A.

6.18%

State Street Investment Management (US)

4.30%

Baillie Gifford & Co.

4.26%

Geode Capital Management, L.L.C.

2.75%

其他

70.24%

持股股東

佔比

The Vanguard Group, Inc.

12.28%

BlackRock Institutional Trust Company, N.A.

6.18%

State Street Investment Management (US)

4.30%

Baillie Gifford & Co.

4.26%

Geode Capital Management, L.L.C.

2.75%

其他

70.24%

股東類型

持股股東

佔比

Investment Advisor

56.32%

Investment Advisor/Hedge Fund

28.54%

Research Firm

3.44%

Hedge Fund

3.01%

Pension Fund

2.02%

Bank and Trust

1.84%

Sovereign Wealth Fund

1.50%

Venture Capital

0.40%

Individual Investor

0.36%

其他

2.55%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

2148

383.02M

97.67%

-30.18M

2025Q2

2212

390.97M

99.70%

-27.53M

2025Q1

2252

386.55M

98.59%

-25.17M

2024Q4

2220

380.88M

97.47%

-26.96M

2024Q3

2145

382.31M

97.83%

-30.58M

2024Q2

2115

397.02M

99.11%

-4.31M

2024Q1

2093

389.18M

98.33%

-19.87M

2023Q4

2081

398.01M

103.26%

+83.33K

2023Q3

1994

389.89M

100.89%

-11.88M

2023Q2

1952

389.17M

100.78%

-12.73M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

48.15M

12.28%

+859.71K

+1.82%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

24.25M

6.18%

-475.12K

-1.92%

Jun 30, 2025

State Street Investment Management (US)

16.86M

4.3%

+175.27K

+1.05%

Jun 30, 2025

Baillie Gifford & Co.

16.71M

4.26%

+2.53M

+17.81%

Jun 30, 2025

Geode Capital Management, L.L.C.

10.77M

2.75%

+358.62K

+3.45%

Jun 30, 2025

Jennison Associates LLC

11.52M

2.94%

+994.30K

+9.45%

Jun 30, 2025

Sands Capital Management, LLC

9.95M

2.54%

-466.21K

-4.48%

Jun 30, 2025

Invesco Capital Management (QQQ Trust)

8.03M

2.05%

-28.35K

-0.35%

Aug 31, 2025

Nuveen LLC

7.30M

1.86%

-549.07K

-7.00%

Jun 30, 2025

MFS Investment Management

6.49M

1.65%

+3.30M

+103.55%

Jun 30, 2025

持股ETF



更新時間: 10月6日週一

機構名稱

佔比

First Trust Nasdaq Lux Digi Health Solutions ETF

6.79%

Langar Global HealthTech ETF

5.33%

Global X Internet of Things ETF

5.24%

Global X HealthTech ETF

3.89%

Fidelity Digital Health ETF

3.79%

Harbor Health Care ETF

3.48%

iShares U.S. Medical Devices ETF

3.39%

Touchstone Sands Capital US Select Growth ETF

3.06%

Goldman Sachs Future Health Care Equity ETF

2.68%

Motley Fool Global Opportunities ETF

2.43%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比6.79%

Langar Global HealthTech ETF

佔比5.33%

Global X Internet of Things ETF

佔比5.24%

Global X HealthTech ETF

佔比3.89%

Fidelity Digital Health ETF

佔比3.79%

Harbor Health Care ETF

佔比3.48%

iShares U.S. Medical Devices ETF

佔比3.39%

Touchstone Sands Capital US Select Growth ETF

佔比3.06%

Goldman Sachs Future Health Care Equity ETF

佔比2.68%

Motley Fool Global Opportunities ETF

佔比2.43%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

Mar 28, 2022

Split

1→4

公告日期

類型

比率

Mar 28, 2022

Split

1→4